Your horse's mobility matters at every moment.

Help extend your horse’s mobility over a lifetime with vigilance and action today. Brought to you by BloodHorse.com Partners | [View this promotional email in browser]( | [Unsubscribe]( Be sure to add partners@BloodHorse.com to your address book or safe sender list so our emails get to your inbox. [Adequan® i.m. Mobility Matters]( [Mobility matters in every stage of your horse’s life] Mobility Matters in every stage of your horse’s life & career Work with your veterinarian to extend your horse’s mobility span.1 A single horse can be part of our lives for decades, and different management strategies are needed to keep that horse moving soundly. To maintain mobility, and ultimately quality of life, it is critical to detect and address joint problems early to maximize outcomes.2 In short, when it comes to joint health, it pays to stay proactive. Ask your veterinarian how Adequan® i.m. can help horses enjoy greater mobility over a lifetime3-5 [Lifestages Chart] INDICATIONS Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. IMPORTANT SAFETY INFORMATION There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, [click here.]( Keep your horse’s mobility top of mind with email notifications from Adequan® i.m. [Sign Up Now]( 1. McFarlane D. "How to Establish a HealthCare Program for the Aging Horse in Equine Practice," AAEP Proceedings, 62: 2016. 2. USDA. Equine 2015: “Changes in the U.S. Equine Industry, 1998–2015” USDA–APHIS–VS–CEAH–NAHMS. Fort Collins, CO #723.0517. 3. Kim DY, Taylor HW, Moore RM, Paulsen DB, Cho DY. Articular chondrocyte apoptosis in equine osteoarthritis. The Veterinary Journal 2003; 166: 52-57. 4. McIlwraith CW, Frisbie DD, Kawcak CE, van Weeren PR. Joint Disease in the Horse. St. Louis, MO: Elsevier, 2016; 33-48. 5. Adequan® i.m. Package Insert, Rev 1/19. © 2021, American Regent, Inc. All trademarks are the property of American Regent, Inc. PP-AI-US-0602 02/2021 You are receiving this e-mail because you requested to receive special promotions from BloodHorse and its partners. Please do not reply to this message. The partners@BloodHorse.com e-mail box is not monitored, and any e-mails received at that address will not be read. [Unsubscribe]( | [Contact Us]( | [Privacy Policy]( BloodHorse | 821 Corporate Drive | Lexington, KY 40503 | 800-582-5604